AI Engines For more Details: Perplexity Kagi Labs You
Gastroesophageal Reflux Disease (GERD): Rabeprazole is highly effective in treating GERD, a condition characterized by the backward flow of stomach acid into the esophagus, causing symptoms such as heartburn, regurgitation, and chest pain.
Peptic Ulcers: Rabeprazole is used to treat peptic ulcers, including gastric ulcers (in the stomach) and duodenal ulcers (in the upper part of the small intestine). It helps promote ulcer healing and prevents their recurrence by reducing stomach acid production.
Helicobacter pylori Eradication: Rabeprazole is often prescribed as part of a combination therapy to eradicate Helicobacter pylori bacteria, which can contribute to the development of ulcers and gastritis.
Gastritis: Rabeprazole can help alleviate the symptoms of gastritis, an inflammation of the stomach lining often caused by excessive stomach acid production or Helicobacter pylori infection.
Zollinger-Ellison Syndrome: This rare condition is characterized by the overproduction of stomach acid, leading to severe ulcers in the stomach and small intestine. Rabeprazole is used to manage symptoms and reduce acid secretion in patients with Zollinger-Ellison syndrome.
Non-Ulcer Dyspepsia: Rabeprazole may be prescribed to alleviate symptoms of non-ulcer dyspepsia, including upper abdominal pain, bloating, and discomfort, particularly when these symptoms are related to excess stomach acid.
Prevention of NSAID-Induced Ulcers: Nonsteroidal anti-inflammatory drugs (NSAIDs) can cause gastrointestinal ulcers and bleeding. Rabeprazole is sometimes prescribed to individuals taking NSAIDs long-term to reduce the risk of ulcers and associated complications.
Reflux Esophagitis: Rabeprazole is effective in treating reflux esophagitis, a condition characterized by inflammation and damage to the esophagus due to repeated exposure to stomach acid.
Barrett's Esophagus: Rabeprazole may be used as part of the treatment plan for Barrett's esophagus, a complication of GERD characterized by changes in the lining of the esophagus that may increase the risk of esophageal cancer.
Eosinophilic Esophagitis: In some cases, rabeprazole may be prescribed as part of the management of eosinophilic esophagitis, an allergic inflammatory condition of the esophagus that can cause difficulty swallowing and other symptoms.
| Rank | Probiotic | Impact |
|---|---|---|
| genus | Bifidobacterium | Reduces |
| species | Bacteroides uniformis | Reduces |
| species | Bifidobacterium adolescentis | Reduces |
| species | Escherichia coli | Reduces |
| species | Lacticaseibacillus paracasei | Reduces |
| species | Parabacteroides distasonis | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
| π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
|---|---|---|---|---|
| 0 | 1 | Aspergillaceae | family | Decreases |
| 0 | 1 | Escherichia | genus | Decreases |
| 0 | 1 | Dorea | genus | Decreases |
| 0 | 1 | Roseburia | genus | Decreases |
| 1 | 0 | Aspergillus | genus | Decreases |
| 0 | 1 | Parabacteroides | genus | Decreases |
| 0 | 1 | Ruminococcus | genus | Decreases |
| 0 | 1 | Agathobacter | genus | Decreases |
| 0 | 1 | Bacteroides | genus | Decreases |
| 0 | 1 | Bifidobacterium | genus | Decreases |
| 0 | 1 | Bilophila | genus | Decreases |
| 0 | 1 | Collinsella | genus | Decreases |
| 0 | 1 | Coprococcus | genus | Decreases |
| 0 | 1 | Fusobacterium | genus | Decreases |
| 0 | 1 | Lachnospira | genus | Decreases |
| 0 | 1 | Mediterraneibacter | genus | Decreases |
| 0 | 1 | Phocaeicola | genus | Decreases |
| 0 | 1 | Streptococcus | genus | Decreases |
| 0 | 1 | Clostridium | genus | Decreases |
| 0 | 1 | Segatella | genus | Decreases |
| 0 | 1 | Enterocloster | genus | Decreases |
| 0 | 1 | Blautia | genus | Decreases |
| 0 | 1 | Thomasclavelia | genus | Decreases |
| 0 | 1 | Lacticaseibacillus | genus | Decreases |
| 0 | 1 | Candida | genus | Decreases |
| 0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
| 0 | 1 | Clostridium perfringens A | no rank | Decreases |
| 0 | 1 | Clostridium perfringens C | no rank | Decreases |
| 0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
| 0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
| 0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
| 0 | 1 | Clostridium perfringens D | no rank | Decreases |
| 0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
| 0 | 1 | Clostridium perfringens B | no rank | Decreases |
| 0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
| 0 | 1 | Clostridium perfringens E | no rank | Decreases |
| 0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
| 0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
| 0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
| 0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
| 0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
| 0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
| 0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
| 0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
| 0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
| 0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
| 0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
| 0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
| 0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
| 0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
| 0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
| 0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
| 0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
| 0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
| 0 | 1 | Escherichia coli O111 | serogroup | Decreases |
| 0 | 1 | Escherichia coli O121 | serogroup | Decreases |
| 0 | 1 | Escherichia coli O155 | serogroup | Decreases |
| 0 | 1 | Escherichia coli O177 | serogroup | Decreases |
| 0 | 1 | Escherichia coli O26 | serogroup | Decreases |
| 0 | 1 | Escherichia coli O3 | serogroup | Decreases |
| 0 | 1 | Escherichia coli O5 | serogroup | Decreases |
| 0 | 1 | Escherichia coli O86 | serogroup | Decreases |
| 0 | 1 | Escherichia coli O91 | serogroup | Decreases |
| 0 | 1 | Escherichia coli O103 | serogroup | Decreases |
| 0 | 1 | Escherichia coli O78 | serogroup | Decreases |
| 0 | 1 | Escherichia coli O43 | serogroup | Decreases |
| 0 | 1 | Escherichia coli O119 | serogroup | Decreases |
| 0 | 1 | Escherichia coli O157 | serogroup | Decreases |
| 0 | 1 | Escherichia coli O145 | serogroup | Decreases |
| 0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
| 0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
| 0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
| 0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
| 0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
| 0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
| 0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
| 0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
| 0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
| 0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
| 0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
| 0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
| 0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
| 0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
| 0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
| 0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
| 0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
| 0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
| 0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
| 0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
| 0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
| 0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
| 0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
| 0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
| 0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
| 0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
| 0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
| 0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
| 0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
| 0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
| 0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
| 0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
| 0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
| 0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
| 0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
| 0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
| 0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
| 0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
| 0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
| 0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
| 0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
| 0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
| 0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
| 0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
| 0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
| 0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
| 0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
| 0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
| 0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
| 0 | 1 | Escherichia coli H20 | serotype | Decreases |
| 0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
| 0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
| 0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
| 0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
| 0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
| 0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
| 0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
| 0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
| 0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
| 0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
| 0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
| 0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
| 0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
| 0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
| 0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
| 0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
| 0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
| 0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
| 0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
| 0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
| 0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
| 0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
| 0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
| 0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
| 0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
| 0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
| 0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
| 0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
| 0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
| 0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
| 0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
| 0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
| 0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
| 1 | 0 | Lachnospira eligens | species | Decreases |
| 1 | 0 | Phocaeicola vulgatus | species | Decreases |
| 1 | 0 | [Ruminococcus] torques | species | Decreases |
| 1 | 0 | Agathobacter rectalis | species | Decreases |
| 1 | 0 | Bacteroides fragilis | species | Decreases |
| 1 | 0 | Bilophila wadsworthia | species | Decreases |
| 1 | 0 | Blautia obeum | species | Decreases |
| 1 | 0 | Clostridium perfringens | species | Decreases |
| 1 | 0 | Coprococcus comes | species | Decreases |
| 1 | 0 | Dorea formicigenerans | species | Decreases |
| 1 | 0 | Escherichia coli | species | Decreases |
| 1 | 0 | Fusobacterium nucleatum | species | Decreases |
| 1 | 0 | Mediterraneibacter gnavus | species | Decreases |
| 1 | 0 | Parabacteroides distasonis | species | Decreases |
| 1 | 0 | Parabacteroides merdae | species | Decreases |
| 1 | 0 | Roseburia intestinalis | species | Decreases |
| 1 | 0 | Ruminococcus bromii | species | Decreases |
| 1 | 0 | Streptococcus parasanguinis | species | Decreases |
| 1 | 0 | Candida albicans | species | Decreases |
| 1 | 0 | Collinsella aerofaciens | species | Decreases |
| 1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
| 1 | 0 | Segatella copri | species | Decreases |
| 1 | 0 | Enterocloster bolteae | species | Decreases |
| 0 | 1 | Aspergillus alliaceus | species | Decreases |
| 0 | 1 | Aspergillus bombycis | species | Decreases |
| 0 | 1 | Aspergillus caelatus | species | Decreases |
| 0 | 1 | Aspergillus campestris | species | Decreases |
| 0 | 1 | Aspergillus candidus | species | Decreases |
| 0 | 1 | Aspergillus costaricensis | species | Decreases |
| 0 | 1 | Aspergillus eucalypticola | species | Decreases |
| 0 | 1 | Aspergillus felis | species | Decreases |
| 0 | 1 | Aspergillus fijiensis | species | Decreases |
| 0 | 1 | Aspergillus giganteus | species | Decreases |
| 0 | 1 | Aspergillus heteromorphus | species | Decreases |
| 0 | 1 | Aspergillus hiratsukae | species | Decreases |
| 0 | 1 | Aspergillus homomorphus | species | Decreases |
| 0 | 1 | Aspergillus ibericus | species | Decreases |
| 0 | 1 | Aspergillus japonicus | species | Decreases |
| 0 | 1 | Aspergillus lentulus | species | Decreases |
| 0 | 1 | Aspergillus mulundensis | species | Decreases |
| 0 | 1 | Aspergillus neoniger | species | Decreases |
| 0 | 1 | Aspergillus nomiae | species | Decreases |
| 0 | 1 | Aspergillus novofumigatus | species | Decreases |
| 0 | 1 | Aspergillus phoenicis | species | Decreases |
| 0 | 1 | Aspergillus piperis | species | Decreases |
| 0 | 1 | Aspergillus pseudotamarii | species | Decreases |
| 0 | 1 | Aspergillus ruber | species | Decreases |
| 0 | 1 | Aspergillus saccharolyticus | species | Decreases |
| 0 | 1 | Aspergillus sclerotioniger | species | Decreases |
| 0 | 1 | Aspergillus sojae | species | Decreases |
| 0 | 1 | Aspergillus tanneri | species | Decreases |
| 0 | 1 | Aspergillus thermomutatus | species | Decreases |
| 0 | 1 | Aspergillus tubingensis | species | Decreases |
| 0 | 1 | Aspergillus uvarum | species | Decreases |
| 0 | 1 | Aspergillus vadensis | species | Decreases |
| 0 | 1 | Aspergillus viridinutans | species | Decreases |
| 0 | 1 | Aspergillus welwitschiae | species | Decreases |
| 1 | 0 | Bacteroides uniformis | species | Decreases |
| 1 | 0 | Thomasclavelia ramosa | species | Decreases |
| 0 | 1 | Aspergillus luchuensis | species | Decreases |
| 1 | 0 | Streptococcus salivarius | species | Decreases |
| 1 | 0 | Bifidobacterium adolescentis | species | Decreases |
| 0 | 1 | Aspergillus puulaauensis | species | Decreases |
| 0 | 1 | Aspergillus subgen. Aspergillus | subgenus | Decreases |
| 0 | 1 | Aspergillus subgen. Circumdati | subgenus | Decreases |
| 0 | 1 | Aspergillus subgen. Cremei | subgenus | Decreases |
| 0 | 1 | Aspergillus subgen. Fumigati | subgenus | Decreases |
| 0 | 1 | Aspergillus subgen. Nidulantes | subgenus | Decreases |
| 0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
| 0 | 1 | Fusobacterium nucleatum subsp. nucleatum | subspecies | Decreases |
| 0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Abdominal Aortic Aneurysm | 0.8 | 0.8 | |
| Acne | 0.6 | 0.9 | -0.5 |
| ADHD | 2.7 | 0.6 | 3.5 |
| Age-Related Macular Degeneration and Glaucoma | 1.1 | 0.4 | 1.75 |
| Allergic Rhinitis (Hay Fever) | 4.2 | 1.9 | 1.21 |
| Allergies | 6.9 | 3.4 | 1.03 |
| Allergy to milk products | 2 | 1.6 | 0.25 |
| Alopecia (Hair Loss) | 1.6 | 1.6 | |
| Alzheimer's disease | 6.7 | 6.5 | 0.03 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 3.9 | 1.4 | 1.79 |
| Ankylosing spondylitis | 4.3 | 1.8 | 1.39 |
| Anorexia Nervosa | 1.6 | 2.9 | -0.81 |
| Antiphospholipid syndrome (APS) | 1.5 | 0.3 | 4 |
| Asthma | 5.2 | 1.5 | 2.47 |
| Atherosclerosis | 3.2 | 2.3 | 0.39 |
| Atrial fibrillation | 3.8 | 2.8 | 0.36 |
| Autism | 9.8 | 9 | 0.09 |
| Autoimmune Disease | 1.2 | 1 | 0.2 |
| Barrett esophagus cancer | 0.3 | 0.3 | 0 |
| benign prostatic hyperplasia | 0.6 | 0.3 | 1 |
| Biofilm | 3.2 | 3.2 | |
| Bipolar Disorder | 2.1 | 1.1 | 0.91 |
| Brain Trauma | 0.9 | 1.4 | -0.56 |
| Breast Cancer | 1.8 | 0.3 | 5 |
| Cancer (General) | 0.3 | 1.1 | -2.67 |
| Carcinoma | 4.9 | 2.3 | 1.13 |
| Celiac Disease | 3.5 | 2.6 | 0.35 |
| Cerebral Palsy | 1.1 | 1.3 | -0.18 |
| Chronic Fatigue Syndrome | 4.1 | 6.9 | -0.68 |
| Chronic Kidney Disease | 3.4 | 2.9 | 0.17 |
| Chronic Lyme | 0.8 | -0.8 | |
| Chronic Obstructive Pulmonary Disease (COPD) | 3.2 | 1.7 | 0.88 |
| Chronic Urticaria (Hives) | 1.7 | 0.9 | 0.89 |
| Coagulation / Micro clot triggering bacteria | 1.9 | 1.3 | 0.46 |
| Cognitive Function | 3.6 | 1.5 | 1.4 |
| Colorectal Cancer | 8.1 | 3.1 | 1.61 |
| Constipation | 2.7 | 2.3 | 0.17 |
| Coronary artery disease | 3 | 2.5 | 0.2 |
| COVID-19 | 7.7 | 9.8 | -0.27 |
| Crohn's Disease | 9.1 | 6.1 | 0.49 |
| Cushing's Syndrome (hypercortisolism) | 1 | -1 | |
| cystic fibrosis | 1.7 | 1.3 | 0.31 |
| d-lactic acidosis (one form of brain fog) | 0.6 | 0.6 | |
| deep vein thrombosis | 3.7 | 1.4 | 1.64 |
| Denture Wearers Oral Shifts | 1.5 | 1.5 | |
| Depression | 9.6 | 8.5 | 0.13 |
| Dermatomyositis | 0.3 | 0.3 | 0 |
| Eczema | 2.5 | 2.1 | 0.19 |
| Endometriosis | 3.5 | 2 | 0.75 |
| Eosinophilic Esophagitis | 0.3 | 0.3 | 0 |
| Epilepsy | 4 | 1.7 | 1.35 |
| erectile dysfunction | 2.1 | 0.3 | 6 |
| Fibromyalgia | 2.9 | 2.8 | 0.04 |
| Functional constipation / chronic idiopathic constipation | 5.4 | 4 | 0.35 |
| gallstone disease (gsd) | 4 | 1.1 | 2.64 |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 2.7 | 1.2 | 1.25 |
| Generalized anxiety disorder | 3.1 | 1.9 | 0.63 |
| giant cell arteritis | 0.2 | -0.2 | |
| Glioblastoma | 0.3 | -0.3 | |
| Gout | 1.5 | 1.4 | 0.07 |
| Graves' disease | 1.6 | 3 | -0.88 |
| Gulf War Syndrome | 0.9 | 0.9 | 0 |
| Halitosis | 1.5 | 0.3 | 4 |
| Hashimoto's thyroiditis | 3.6 | 1.8 | 1 |
| Heart Failure | 5.6 | 2.8 | 1 |
| hemorrhagic stroke | 1.3 | 1.3 | |
| Hidradenitis Suppurativa | 1.4 | 1.4 | |
| High Histamine/low DAO | 1.9 | 0.6 | 2.17 |
| hypercholesterolemia (High Cholesterol) | 0.8 | 0.8 | |
| hyperglycemia | 1.3 | 1.1 | 0.18 |
| Hyperlipidemia (High Blood Fats) | 0.9 | 0.3 | 2 |
| hypersomnia | 0.7 | -0.7 | |
| hypertension (High Blood Pressure | 4.7 | 3.8 | 0.24 |
| Hypothyroidism | 0.9 | 0.7 | 0.29 |
| Hypoxia | 3.6 | 0.6 | 5 |
| IgA nephropathy (IgAN) | 1.6 | 2.8 | -0.75 |
| Inflammatory Bowel Disease | 6.6 | 8.9 | -0.35 |
| Insomnia | 2 | 2.6 | -0.3 |
| Intelligence | 1.5 | 0.3 | 4 |
| Intracranial aneurysms | 1.4 | 0.9 | 0.56 |
| Irritable Bowel Syndrome | 6.6 | 4 | 0.65 |
| ischemic stroke | 2.3 | 1.7 | 0.35 |
| Juvenile idiopathic arthritis | 0.5 | 0.5 | |
| Liver Cirrhosis | 6.1 | 4 | 0.52 |
| liver fibrosis | 0.5 | 0.5 | |
| Long COVID | 5.5 | 6.7 | -0.22 |
| Low bone mineral density | 1.1 | -1.1 | |
| Lung Cancer | 0.9 | 1 | -0.11 |
| Lymphoma | 0.9 | 0.9 | |
| Mast Cell Issues / mastitis | 1.5 | 0.9 | 0.67 |
| ME/CFS with IBS | 0.8 | 2.4 | -2 |
| ME/CFS without IBS | 1.1 | 2.4 | -1.18 |
| membranous nephropathy | 0.3 | 0.3 | |
| Menopause | 0.4 | 0.5 | -0.25 |
| Metabolic Syndrome | 7.6 | 5.4 | 0.41 |
| Mood Disorders | 7.8 | 7.3 | 0.07 |
| multiple chemical sensitivity [MCS] | 0.4 | 0.1 | 3 |
| Multiple Sclerosis | 6.9 | 6.8 | 0.01 |
| Multiple system atrophy (MSA) | 0.6 | 0.7 | -0.17 |
| myasthenia gravis | 0.9 | 0.7 | 0.29 |
| neuropathic pain | 1.6 | -1.6 | |
| Neuropathy (all types) | 0.4 | 2.3 | -4.75 |
| neuropsychiatric disorders (PANDAS, PANS) | 0.9 | 0.9 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 4.9 | 3.9 | 0.26 |
| NonCeliac Gluten Sensitivity | 1 | 0.6 | 0.67 |
| Obesity | 8.9 | 6.6 | 0.35 |
| obsessive-compulsive disorder | 5.1 | 3.7 | 0.38 |
| Osteoarthritis | 2.4 | 1.2 | 1 |
| Osteoporosis | 2.6 | 1.6 | 0.63 |
| pancreatic cancer | 1.8 | 0.6 | 2 |
| Parkinson's Disease | 7.5 | 8.1 | -0.08 |
| Polycystic ovary syndrome | 7.9 | 2.9 | 1.72 |
| Postural orthostatic tachycardia syndrome | 0.2 | 0.6 | -2 |
| Premenstrual dysphoric disorder | 0.7 | 0.4 | 0.75 |
| primary biliary cholangitis | 0.9 | 1.2 | -0.33 |
| Primary sclerosing cholangitis | 2.1 | 3.2 | -0.52 |
| Psoriasis | 3.9 | 3.1 | 0.26 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 8.3 | 4.1 | 1.02 |
| Rosacea | 1.2 | 1 | 0.2 |
| Schizophrenia | 5.8 | 2.8 | 1.07 |
| scoliosis | 0.9 | 1.3 | -0.44 |
| Sjögren syndrome | 1.8 | 2.2 | -0.22 |
| Sleep Apnea | 2.2 | 1.6 | 0.38 |
| Slow gastric motility / Gastroparesis | 1.2 | 0.3 | 3 |
| Small Intestinal Bacterial Overgrowth (SIBO) | 2 | 2 | |
| Stress / posttraumatic stress disorder | 3.2 | 2.1 | 0.52 |
| Systemic Lupus Erythematosus | 4.5 | 1.6 | 1.81 |
| Tic Disorder | 1.3 | 1.5 | -0.15 |
| Tourette syndrome | 0.9 | 0.3 | 2 |
| Type 1 Diabetes | 5.3 | 3.6 | 0.47 |
| Type 2 Diabetes | 9 | 6.2 | 0.45 |
| Ulcerative colitis | 6.3 | 5 | 0.26 |
| Unhealthy Ageing | 5.4 | 2.2 | 1.45 |
| Vitiligo | 2.5 | 1.5 | 0.67 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]